TP53 and polycystic ovary syndrome: We performed KEGG enrichment analysis on 88 potential therapeutic targets of KTC for PCOS, and found that molecular mechanisms of KTC's treatment of PCOS might be related to IL-17 signaling pathway, TNF signaling pathway, p53 signaling pathway, Toll-like receptor, and so on.